Viewing Study NCT01227512

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2025-12-26 @ 11:13 PM
Study NCT ID: NCT01227512
Status: TERMINATED
Last Update Posted: 2014-10-30
First Post: 2010-10-22
Is NOT Gene Therapy: False
Has Adverse Events: True
Brief Title: Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hyponatremia View
None Dilutional Hyponatremia View
None Inappropriate ADH Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hyponatremia View
None Dilutional Hyponatremia View
None Euvolemic Hyponatremia View
None Hypervolemic Hyponatremia View
None Fluid Restriction View
None Tolvaptan View